Paul M. Hassoun
About
Paul M. Hassoun is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine.
According to data from OpenAlex, Paul M. Hassoun has authored 279 papers receiving a total of 16.0k indexed citations (citations by other indexed papers that have themselves been cited), including 229 papers in Pulmonary and Respiratory Medicine, 97 papers in Cardiology and Cardiovascular Medicine and 58 papers in Pathology and Forensic Medicine. Recurrent topics in Paul M. Hassoun's work include Pulmonary Hypertension Research and Treatments (204 papers), Cardiovascular Function and Risk Factors (61 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (54 papers). Paul M. Hassoun is often cited by papers focused on Pulmonary Hypertension Research and Treatments (204 papers), Cardiovascular Function and Risk Factors (61 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (54 papers). Paul M. Hassoun collaborates with scholars based in United States, Germany and Italy. Paul M. Hassoun's co-authors include Stephen C. Mathai, Reda E. Girgis, Hunter C. Champion, Rubin M. Tuder, Micah R. Fisher, Rohit Budhiraja, Paul R. Forfia, Traci Housten-Harris, Rachel L. Damico and Evangelos D. Michelakis and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.
In The Last Decade
Paul M. Hassoun
270 papers receiving 15.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Paul M. Hassoun United States | 64 | 11.6k | 6.7k | 2.6k | 2.2k | 1.9k | 279 | 16.0k | ||
| David Montani France | 67 | 13.8k 1.2× | 6.7k 1.0× | 2.3k 0.9× | 1.2k 0.5× | 1.3k 0.7× | 397 | 16.6k | ||
| Harrison W. Farber United States | 52 | 9.1k 0.8× | 5.7k 0.9× | 1.9k 0.7× | 910 0.4× | 1.5k 0.8× | 254 | 13.5k | ||
| Ralph T. Schermuly Germany | 72 | 13.8k 1.2× | 6.2k 0.9× | 5.8k 2.2× | 662 0.3× | 1.0k 0.5× | 397 | 20.0k | ||
| Norbert F. Voelkel United States | 84 | 16.8k 1.5× | 8.1k 1.2× | 6.1k 2.4× | 821 0.4× | 2.1k 1.1× | 274 | 24.8k | ||
| Carlyne D. Cool United States | 58 | 8.9k 0.8× | 2.2k 0.3× | 2.5k 0.9× | 639 0.3× | 1.2k 0.7× | 173 | 11.8k | ||
| Élie Fadel France | 66 | 9.3k 0.8× | 4.1k 0.6× | 2.1k 0.8× | 387 0.2× | 1.1k 0.6× | 355 | 12.8k | ||
| Zhi‐Cheng Jing China | 39 | 8.6k 0.7× | 5.8k 0.9× | 1.3k 0.5× | 553 0.2× | 1.0k 0.5× | 221 | 10.6k | ||
| David B. Badesch United States | 62 | 23.3k 2.0× | 15.2k 2.3× | 1.9k 0.7× | 2.0k 0.9× | 2.3k 1.2× | 180 | 25.9k | ||
| Stephan Rosenkranz Germany | 54 | 5.2k 0.5× | 5.6k 0.8× | 1.9k 0.7× | 466 0.2× | 860 0.5× | 267 | 10.0k | ||
| Yasuhiko Tomino Japan | 57 | 2.5k 0.2× | 2.8k 0.4× | 3.7k 1.4× | 2.4k 1.1× | 1.5k 0.8× | 626 | 19.7k |
Countries citing papers authored by Paul M. Hassoun
Since
Specialization
Citations
This map shows the geographic impact of Paul M. Hassoun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Hassoun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Hassoun more than expected).
Fields of papers citing papers by Paul M. Hassoun
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Paul M. Hassoun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Hassoun. The network helps show where Paul M. Hassoun may publish in the future.
Co-authorship network of co-authors of Paul M. Hassoun
This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. Hassoun. A scholar is included among the top collaborators of Paul M. Hassoun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. Hassoun. Paul M. Hassoun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mukherjee, Monica, Lawrence Rudski, Karima Addetia, et al.. (2025). Guidelines for the Echocardiographic Assessment of the Right Heart in Adults and Special Considerations in Pulmonary Hypertension: Recommendations from the American Society of Echocardiography. Journal of the American Society of Echocardiography. 38(3). 141–186.
2.
Gao, Li, John Skinner, Tanmay Nath, et al.. (2024). Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension. Respiratory Research. 25(1). 235–235.
3.
Humbert, Marc, Paul M. Hassoun, Kelly Chin, et al.. (2024). MK-5475, an inhaled soluble guanylate cyclase stimulator, for treatment of pulmonary arterial hypertension: the INSIGNIA-PAH study. European Respiratory Journal. 64(5). 2401110–2401110.
4.
Scheel, Paul J., Monica Mukherjee, Nisha A. Gilotra, et al.. (2023). Occult right ventricular dysfunction and right ventricular-vascular uncoupling in left ventricular assist device recipients. The Journal of Heart and Lung Transplantation. 43(4). 594–603.
5.
Lahm, Tim, Ivor S. Douglas, Stephen L. Archer, et al.. (2018). Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement. American Journal of Respiratory and Critical Care Medicine. 198(4). e15–e43.
6.
Kelemen, Benjamin W., Stephen C. Mathai, Rachel L. Damico, et al.. (2017). Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction. Pulmonary Circulation. 7(2). 409–420.
7.
Mercurio, Valentina, Monica Mukherjee, Ryan J. Tedford, et al.. (2017). Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 197(3). 388–391.
8.
Hassoun, Paul M., Roham T. Zamanian, Rachel L. Damico, et al.. (2015). Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 192(9). 1102–1110.
9.
Dweik, Raed A., Sharon Rounds, Serpil C. Erzurum, et al.. (2014). An Official American Thoracic Society Statement: Pulmonary Hypertension Phenotypes. American Journal of Respiratory and Critical Care Medicine. 189(3). 345–355.
10.
Tedford, Ryan J., James O. Mudd, Reda E. Girgis, et al.. (2013). Right Ventricular Dysfunction in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension. Circulation Heart Failure. 6(5). 953–963.
11.
Hoeper, Marius M., Robyn J. Barst, Robert C. Bourge, et al.. (2013). Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension. Circulation. 127(10). 1128–1138.
12.
Pavec, Jérôme Le, Marc Humbert, Luc Mouthon, & Paul M. Hassoun. (2010). Systemic Sclerosis-associated Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 181(12). 1285–1293.
13.
Campo, Arantza, Stephen C. Mathai, Jérôme Le Pavec, et al.. (2010). Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 182(2). 252–260.
14.
Fisher, Micah R., Paul R. Forfia, Elzbieta Chamera, et al.. (2009). Accuracy of Doppler Echocardiography in the Hemodynamic Assessment of Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 179(7). 615–621.
15.
Reddy, Narsa M., Melinda S. Yates, Steven R. Kleeberger, et al.. (2009). The Triterpenoid CDDO-Imidazolide Confers Potent Protection against Hyperoxic Acute Lung Injury in Mice. American Journal of Respiratory and Critical Care Medicine. 180(9). 867–874.
16.
Finigan, James H., Adel Boueiz, Emily Wilkinson, et al.. (2009). Activated protein C protects against ventilator-induced pulmonary capillary leak. American Journal of Physiology-Lung Cellular and Molecular Physiology. 296(6). L1002–L1011.
17.
Forfia, Paul R., Stephen C. Mathai, Micah R. Fisher, et al.. (2008). Hyponatremia Predicts Right Heart Failure and Poor Survival in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 177(12). 1364–1369.
18.
Papaiahgari, Srinivas, Swetha Reddy, Narsa M. Reddy, et al.. (2007). Genetic and Pharmacologic Evidence Links Oxidative Stress to Ventilator-induced Lung Injury in Mice. American Journal of Respiratory and Critical Care Medicine. 176(12). 1222–1235.
19.
Forfia, Paul R., Micah R. Fisher, Stephen C. Mathai, et al.. (2006). Tricuspid Annular Displacement Predicts Survival in Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 174(9). 1034–1041.
20.
Hassoun, Paul M., Fengsheng Yu, Claudia Côté, et al.. (1998). Upregulation of Xanthine Oxidase by Lipopolysaccharide, Interleukin-1, and Hypoxia: Role in Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 158(1). 299–305.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by David Montani Breakdown of academic impact, for papers by Harrison W. Farber Breakdown of academic impact, for papers by Ralph T. Schermuly Breakdown of academic impact, for papers by Norbert F. Voelkel Breakdown of academic impact, for papers by Carlyne D. Cool Breakdown of academic impact, for papers by Élie Fadel Breakdown of academic impact, for papers by Zhi‐Cheng Jing Breakdown of academic impact, for papers by David B. Badesch Breakdown of academic impact, for papers by Stephan Rosenkranz Breakdown of academic impact, for papers by Yasuhiko Tomino